WASHINGTON UNIVERSITY ST. LOUIS;Eli Lilly & Company
发明人:
申请号：
EP16161726.1
公开号：
EP3070100A1
申请日:
2001.02.26
申请国别(地区):
EP
年份:
2016
代理人:
摘要：
A method to treat conditions characterized by formation of amyloid plaques both prophylactically and therapeutically is described. The method employs humanized antibodies which sequester soluble Aß peptide from human biological fluids or which preferably specifically bind an epitope contained within position 13-28 of the amyloid beta peptide Aß.
